Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.
Posted on Feb 23, 2017
EDEN PRAIRIE, Minn., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that its fourth quarter 2016 results will be released on Thursday, March 2, 2017, before the open of the stock market. The company will host a conference call and webcast at 9:00 AM ET that mor...
Posted on Feb 10, 2017
EDEN PRAIRIE, Minn., Feb. 10, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) announced today that on February 9, 2017, the Company received formal notice from The NASDAQ Stock Market LLC indicating that the Company has evidenced compliance with the minimum $1.00 bid price requirement, ...
Posted on Feb 3, 2017
EDEN PRAIRIE, Minn., Feb. 03, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) (ASX:SHC) today announced that Steven F. Brandt and Matthew E. Likens have been appointed to the Company's Board of Directors.
Mr. Brandt is a senior executive with over 35 years of experience in the heal...
Events & Presentations
Posted on Mar 2, 2017 at 9:00 AM ET